|  Help  |  About  |  Contact Us

Publication : ARL6IP5 Ameliorates α-Synuclein Burden by Inducing Autophagy via Preventing Ubiquitination and Degradation of ATG12.

First Author  Siddique I Year  2023
Journal  Int J Mol Sci Volume  24
Issue  13 PubMed ID  37445677
Mgi Jnum  J:337948 Mgi Id  MGI:7508382
Doi  10.3390/ijms241310499 Citation  Siddique I, et al. (2023) ARL6IP5 Ameliorates alpha-Synuclein Burden by Inducing Autophagy via Preventing Ubiquitination and Degradation of ATG12. Int J Mol Sci 24(13)
abstractText  Recent advanced studies in neurodegenerative diseases have revealed several links connecting autophagy and neurodegeneration. Autophagy is the major cellular degradation process for the removal of toxic protein aggregates responsible for neurodegenerative diseases. More than 30 autophagy-related proteins have been identified as directly participating in the autophagy process. Proteins regulating the process of autophagy are much more numerous and unknown. To address this, in our present study, we identified a novel regulator (ARL6IP5) of neuronal autophagy and showed that the level of ARL6IP5 decreases in the brain with age and in Parkinson's disease in mice and humans. Moreover, a cellular model of PD (Wild type and A53T mutant alpha-synuclein overexpression) has also shown decreased levels of ARL6IP5. ARL6IP5 overexpression reduces alpha-synuclein aggregate burden and improves cell survival in an A53T model of Parkinson's disease. Interestingly, detailed mechanistic studies revealed that ARL6IP5 is an autophagy inducer. ARL6IP5 enhances Rab1-dependent autophagosome initiation and elongation by stabilizing free ATG12. We report for the first time that alpha-synuclein downregulates ARL6IP5 to inhibit autophagy-dependent clearance of toxic aggregates that exacerbate neurodegeneration.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

3 Bio Entities

Trail: Publication

0 Expression